Joseph V Pergolizzi

This inventor holds 10 USPTO granted patents and 19 published patent applications, plus 1 CIPO patent and 4 EPO patents. Top assignees: Rtu Pharmaceuticals, LLC, Enalare Therapeutics Inc., Native Cardio, Inc.. Active years: 2016-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Joseph V Pergolizzi. Retrieved from https://idiyas.com/inventor/joseph-v-pergolizzi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 10 (Patent Applications = 19)

% Patents Active = 100.0

CIPO Patents = 1 (Patent Applications = 6)

EPO Patents = 4 (Patent Applications = 12)

Average Co-Inventor Count = 2.6

ph-index = 1

Forward Citations = 4(Granted Patents)

Company Filing History:

4 out of 4

Rtu Pharmaceuticals, LLC

patents

3 out of 3

Enalare Therapeutics Inc.

Years Active: 2016-2026

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12721850 - Large-conductance potassium channel modulators, compositions thereof, methods of manufacturing thereof, and methods of use thereof (2026-09-01),

2. 12544369 - Methods and pharmaceutical compositions to treat drug overdose (2026-02-10),

3. 12138267 - Methods of treating respiratory depression modulated by a non-opioid agent (2024-11-12),

4. 11224718 - Device and methods for targeted tissue drug delivery (2022-01-18),

5. 11116750 - Ready to use ketorolac formulations (2021-09-14),

6. 10456553 - Device and methods for targeted tissue drug delivery (2019-10-29),

7. 10278959 - Ready to use ketorolac formulations (2019-05-07),

8. 10118014 - Device and methods for targeted tissue drug delivery (2018-11-06),

9. 9962371 - Ready to use ketorolac formulations (2018-05-08),

10. 9421191 - Ready to use ketorolac formulations (2016-08-23),

Title: Joseph V Pergolizzi: Innovator in Targeted Drug Delivery

Introduction

Joseph V Pergolizzi is a notable inventor based in Naples, FL (US), recognized for his contributions to the field of drug delivery systems. With a total of 10 patents, he has made significant advancements in the development of innovative medical devices and pharmaceutical formulations.

Latest Patents

Among his latest patents, Pergolizzi has developed a "Device and methods for targeted tissue drug delivery." This invention provides novel, minimally invasive implantable devices and methods for the targeted delivery of cardiovascular drugs. Additionally, he has created "Ready to use ketorolac formulations," which disclose a pharmaceutical composition for parenteral administration.

Career Highlights

Throughout his career, Joseph V Pergolizzi has worked with various companies, including Rtu Pharmaceuticals, LLC and Native Cardio, Inc. His work has focused on enhancing the efficacy and safety of drug delivery methods, particularly in cardiovascular treatments.

Collaborations

Joseph has collaborated with notable professionals in his field, including Alexander Mironov and Chad James Pickens. These collaborations have contributed to the advancement of his innovative projects and patents.

Conclusion

Joseph V Pergolizzi stands out as a significant figure in the realm of medical innovations, particularly in targeted drug delivery systems. His work continues to impact the pharmaceutical industry positively.

Profile summary based on public USPTO records.